Fundraising FoxVafseo
1 known investors
Find your way into Vafseo
Sign up to see every warm intro you have to Vafseo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vafseo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vafseo (vadadustat) is a once-daily oral prescription medicine that treats anemia caused by chronic kidney disease in adults who have been on dialysis for at least three months. It works by increasing erythropoietin to help the body produce more red blood cells, and is marketed by Akebia Therapeutics.
Investors · 1
Frequently asked questions
- What does Vafseo do?
- Vafseo (vadadustat) is a once-daily oral prescription medicine that treats anemia caused by chronic kidney disease in adults who have been on dialysis for at least three months. It works by increasing erythropoietin to help the body produce more red blood cells, and is marketed by Akebia Therapeutics.
- Who are Vafseo's investors?
- Vafseo's investors include HEALTHCARE ROYALTY PARTNERS.